Dr. Reddy's Laboratories Limited (BOM:500124)
India flag India · Delayed Price · Currency is INR
1,224.50
-14.50 (-1.17%)
At close: Oct 23, 2026

Dr. Reddy's Laboratories Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
13,29415,36814,6547,1075,77914,852
Short-Term Investments
62,94872,44643,25474,36356,01829,513
Cash & Short-Term Investments
76,24287,81457,90881,47061,79744,365
Cash Growth
9.21%51.64%-28.92%31.84%39.29%28.32%
Accounts Receivable
101,399101,21990,42080,29872,48566,764
Other Receivables
-4442,9672,9081,4515,051
Receivables
101,399101,66393,38783,20673,93671,815
Inventory
81,18276,53171,08563,55248,67050,884
Prepaid Expenses
-2,0751,8831,9471,4521,138
Other Current Assets
38,75233,89225,84917,87418,39813,654
Total Current Assets
297,575301,975250,112248,049204,253181,856
Property, Plant & Equipment
115,097115,93097,76176,88666,46262,169
Long-Term Investments
16,29516,36815,2025,2555,3627,986
Goodwill
12,98012,89311,8104,2534,2454,418
Other Intangible Assets
104,165105,05996,80336,95130,84927,246
Long-Term Accounts Receivable
-----54
Long-Term Deferred Tax Assets
23,15522,43618,50810,7747,1968,204
Other Long-Term Assets
5,2144,6852,7935,3503,487894
Total Assets
574,481579,346492,989387,518321,854292,827

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
36,08222,36220,05321,54717,85715,971
Accrued Expenses
-47,46243,86440,49438,71636,083
Short-Term Debt
58,26059,13538,04512,7237,39027,082
Current Portion of Long-Term Debt
2,3343,799--3,800-
Current Portion of Leases
-2,2048571,3071,0041,017
Current Income Taxes Payable
2,8054,3103,0282,3422,1441,615
Current Unearned Revenue
-1,5811,9831,4351,9812,576
Other Current Liabilities
55,01026,71322,56216,19112,9539,671
Total Current Liabilities
154,491167,566130,39296,03985,84594,015
Long-Term Debt
11,693-3,8003,800-3,800
Long-Term Leases
-12,2034,0642,1901,2781,946
Long-Term Unearned Revenue
-2,4361,1621,1931,5551,597
Long-Term Deferred Tax Liabilities
16,18715,56814,10890983360
Other Long-Term Liabilities
2,7401,1162,2972,8371,352882
Total Liabilities
185,111198,889155,823106,96890,863102,300

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
835835834834833832
Additional Paid-In Capital
11,47911,36411,13310,7659,6889,280
Retained Earnings
359,005351,984315,793265,910216,479176,467
Treasury Stock
-1,484-1,815-2,264-991-1,269-1,601
Comprehensive Income & Other
16,34414,6957,8924,0325,2605,549
Total Common Equity
386,179377,063333,388280,550230,991190,527
Minority Interest
3,1913,3943,778---
Shareholders' Equity
389,370380,457337,166280,550230,991190,527
Total Liabilities & Equity
574,481579,346492,989387,518321,854292,827

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
72,28777,34146,76620,02013,47233,845
Net Cash (Debt)
3,95510,47311,14261,45048,32510,520
Net Cash Growth
-64.92%-6.00%-81.87%27.16%359.36%146.66%
Net Cash Per Share
4.7512.5713.3673.7258.0912.65
Filing Date Shares Outstanding
832.58832.69832832.64830.78829.79
Total Common Shares Outstanding
832.58832.69832832.64830.78829.79
Working Capital
143,084134,409119,720152,010118,40887,841
Book Value Per Share
463.83452.82400.71336.94278.04229.61
Tangible Book Value
269,034259,111224,775239,346195,897158,863
Tangible Book Value Per Share
323.13311.17270.16287.45235.80191.45
Land
-4,2444,1564,2244,2344,154
Buildings
-31,75128,33527,99226,51924,663
Machinery
-153,266125,303117,082107,20595,100
Construction In Progress
-15,26524,83714,4629,95613,305